Month: <span>June 2017</span>

Home / 2017 / June
Post

Researchers show how a protein prevents the uncontrolled expansion of immune cells

The mammalian immune system consists of millions of individual cells that are produced daily from precursor cells in the bone marrow. During their development, immune cells undergo a rapid expansion, which is interrupted by phases of differentiation to more mature lymphocytes. Alternate phases of proliferation and differentiation occur also during the maturation of antibody-producing B...

Post

Type 1 diabetes: Almost half of patients produce insulin

Type 1 diabetes is often described as a condition in which the body fails to produce the hormone insulin. New research, however, provides further evidence that not all insulin production is lost with the condition, and this may be down to an anti-inflammatory protein. Researchers from Uppsala University in Sweden found that nearly half of...

Post

Researchers develop a technique to visualize and control the neural activities that underlie behavior

Since scientists began studying the brain, they have asked whether the biology they observed can really be tied to external behaviors. Researchers are building a substantial understanding of the biophysical, molecular, and cellular interactions of neurons, but directly relating those interactions to outward behaviors is an ongoing challenge in the field. “The biophysical properties of...

Post

Statins may raise the risk of Parkinson’s disease

Thousands of people across the United States are diagnosed with Parkinson’s disease every year. New research examines the effect of statins on the risk of developing this neurodegenerative disease. Every year, approximately 50,000 people in the U.S. are diagnosed with Parkinson’s disease. The National Institutes of Health (NIH) estimate that half a million people in the country live...

Post

Drug shows promise against vision-robbing disease in seniors

An experimental drug is showing promise against an untreatable eye disease that blinds older adults—and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision. Age-related macular degeneration, or AMD, is the leading cause of vision loss among seniors, gradually eroding crucial central vision. There are...

Post

Computer-designed antibodies target toxins associated with Alzheimer’s disease

Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer’s disease, and stop their production. The researchers used computer-based methods to develop antibodies—the star players of the body’s natural defence system—to target the deposits of misfolded proteins which are a hallmark of Alzheimer’s disease. Early...

Post

A unique amino acid for brain cancer therapy

Photodynamic therapy is often used to treat brain tumors because of its specificity—it can target very small regions containing cancerous cells while sparing the normal cells around it from damage. It works by injecting a drug called a photosensitizer into the bloodstream, where it gathers in cells, and then exposing the drug-filled cells to light....